check_circleStudy Completed
Contraception
Bayer Identifier:
15060
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
Influence of estrogens on DRSP
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
18 - 35 YearsTrial summary
Enrollment Goal
83Trial Dates
June 2010 - March 2011Phase
Phase 1Could I Receive a placebo
N/AProducts
Angeliq (E2/DRSP, BAY86-4891)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Bayer Pharma AG | Berlin, 13353, Germany |
Completed | Dinox GmbH Berlin | Berlin, 10115, Germany |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A